These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9244426)

  • 21. [Clinical detection of CMV in allogeneic bone marrow transplantation--review].
    Wang LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):880-4. PubMed ID: 15631684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: the role of immunosuppression.
    Fiegl M; Gerbitz A; Gaeta A; Campe H; Jaeger G; Kolb HJ
    J Clin Virol; 2005 Nov; 34(3):219-23. PubMed ID: 16129661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ganciclovir and the prevention of CMV disease after allogeneic BMT: policy at the Hammersmith Hospital.
    Ward KN; Roberts IA; van Rhee F
    Bone Marrow Transplant; 1994 Feb; 13(2):230-1. PubMed ID: 8205098
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation.
    Humar A; O'Rourke K; Lipton J; Messner H; Meharchand J; Mahony J; Walker I; Wasi P; McGeer A; Moussa G; Chua R; Mazzulli T
    Bone Marrow Transplant; 1999 Jan; 23(1):45-51. PubMed ID: 10037050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant.
    Seropian S; Ferguson D; Salloum E; Cooper D; Landry ML
    Bone Marrow Transplant; 1998 Sep; 22(5):507-9. PubMed ID: 9733277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
    de Medeiros CR; Moreira VA; Pasquini R
    Bone Marrow Transplant; 2000 Aug; 26(4):443-4. PubMed ID: 10982292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
    Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
    Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.
    Sato M; Matsushima T; Takada S; Hatsumi N; Kim K; Sakuraya M; Saito T; Tamura J; Karasawa M; Murakami H; Naruse T
    Bone Marrow Transplant; 1998 Dec; 22(12):1219-22. PubMed ID: 9894728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow transplantation in Thailand.
    Issaragrisil S
    Bone Marrow Transplant; 1994 Jun; 13(6):721-3. PubMed ID: 7920302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Requirements for early discharge after allogeneic bone marrow transplantation].
    Yasumi M; Karasuno T; Kanashima H; Masaie H; Taniguchi H; Mitsui H; Nakamura H; Hiraoka A
    Rinsho Ketsueki; 2001 Aug; 42(8):601-9. PubMed ID: 11579498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gianotti-Crosti syndrome associated with cytomegalovirus antigenemia after bone marrow transplantation.
    Haki M; Tsuchida M; Kotsuji M; Iijima S; Tamura K; Koike K; Izumi I; Tanaka M; Hirano T
    Bone Marrow Transplant; 1997 Oct; 20(8):691-3. PubMed ID: 9383234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    Peggs KS; Preiser W; Kottaridis PD; McKeag N; Brink NS; Tedder RS; Goldstone AH; Linch DC; Mackinnon S
    Br J Haematol; 2000 Dec; 111(3):782-90. PubMed ID: 11122138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.
    Kanda Y; Mineishi S; Saito T; Seo S; Saito A; Suenaga K; Ohnishi M; Niiya H; Nakai K; Takeuchi T; Kawahigashi N; Shoji N; Ogasawara T; Tanosaki R; Kobayashi Y; Tobinai K; Kami M; Mori S; Suzuki R; Kunitoh H; Takaue Y
    Bone Marrow Transplant; 2001 Feb; 27(4):437-44. PubMed ID: 11313674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus infection and disease after bone marrow transplantation: epidemiology, prevention, and treatment.
    Reusser P
    Bone Marrow Transplant; 1991; 7 Suppl 3():52-6. PubMed ID: 1649656
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience.
    Manteiga R; Martino R; Sureda A; Labeaga R; Brunet S; Sierra J; Rabella N
    Bone Marrow Transplant; 1998 Nov; 22(9):899-904. PubMed ID: 9827819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
    Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.